Baudax Bio, Inc.
BXRXDelisted Feb 15, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001780097
Baudax Bio, Inc. was delisted on Feb 15, 2024; its insiders filed their last Form 4 on Dec 19, 2022; 15 institutions reported holding it in 13F filings for Q3 2023, worth $74.5K in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Baudax Bio, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Baudax Bio, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Henwood Geraldine | President and CEO | 2,427 | Dec 19, 2022 | 0 |
| Churchill Winston J | Director | 46,820 | Jun 17, 2022 | 0 |
| Drechsler Andrew T | Director | 41,656 | Jun 17, 2022 | 0 |
| Ashton William | Director | 42,534 | Jun 17, 2022 | 0 |
| Weisman Wayne | Director | 42,900 | Jun 17, 2022 | 0 |
| Baskies Arnold M | Director | 41,942 | Jun 17, 2022 | 0 |
| Dilmore Jillian | Corporate Controller/Secretary | 15,738 | Jun 17, 2022 | 0 |
| Casten Richard S | Chief Financial Officer | 200,000 | Aug 23, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2022 (view filing) | Dec 15 | 4 days | Henwood GeraldinePresident and CEO | PPurchase | +1.20K | $2.55 | +$3.06K | +97.8%2.43K after | |
| Sep 23, 2021 (view filing) | Sep 22 | 1 day | Henwood GeraldinePresident and CEO | PPurchase | +8.20K | $0.59 | +$4.84K | +2.3%364.5K after | |
| Aug 31, 2021 (view filing) | Aug 31 | Same day | Churchill Winston JDirector | PPurchase | +100.0K | $0.63 | +$63.0K | +63.6%257.2K after | |
| Aug 23, 2021 (view filing) | Aug 20 | 3 days | Casten Richard SChief Financial Officer | PPurchase | +50.0K | $0.51 | +$25.5K | +33.3%200.0K after |